Professor Park graduated the College of Medicine Inje University in Busan City, South Korea in 1989 (summa cum laude). He received internal medicine residency & endocrinology fellowship training at Inje University Busan Paik Hospital. Professor Park get his Ph.D. degree with the field epidemiology paper titled as “The characteristics of insulin resistance of the people living at Kijang County Busan City using Homeostasis Model Assessment Method” in 1995. He worked for 2 years as a research associate at the department of pharmaceutics in the University of Utah, SLC UT USA. His initial research interest focused on the non-viral gene therapy for type 2 diabetes mellitus using mini-circle plasmid containing adiponectin cDNA. He published several important and interesting papers on non-viral gene therapy in various high impact journals including the Expert Opinion on Drug Delivery, Journal of Controlled Release and Journal of Gene Medicine etc. He also has joined as a co-investigator in over 100 prospective clinical trials on clinical diabetes management and novel drug development. He worked as the director of Sub-Specialty Board Examination Committee on Endocrinology & Metabolism in South Korea, and the president of Endocrinology & Diabetes Society in South East Part of South Korea. He was also the vice president of Korean Diabetes Association. Now he is a professor of medicine at Inje University Busan Paik Hospital, and is the president of the Korean Endocrine Gerontology Study Group, and the Korean Endocrine Disrupting Chemicals Study Group. He is also the director of CCD (Cities Changing Diabetes) Busan.